# PenPeptides.is

> PenPeptides is developing a dual-chamber pen format for premium peptide research. The device keeps lyophilized peptide and diluent separated in a single pen and mixes them at the moment of activation, so researchers get precise dosing, instant activation, and full potency at every shot without vial reconstitution or premixed-pen degradation. From the makers of Peptide.POWER and NAD.Power. The product is currently in active development.

## About
- Brand: PenPeptides (PenPeptides.is)
- Concept: dual-chamber research-peptide delivery pen - lyophilized peptide plus diluent, mixed at activation, dry until used
- Status: in active development
- Sister brands: Peptide.POWER (https://peptidepower.is) - research peptides shipped across Europe; NAD.Power (https://nadpower.is) - NAD+ and precursors
- Contact: cs@penpeptides.is (information and wholesale prices)
- Languages: homepage available in 33 locales; articles in English

## Articles
- [The Retatrutide Pen: A Researcher's Guide to Premixed, Dual-Chamber Delivery](https://penpeptides.is/retatrutide-pen-guide): why dual-chamber delivery matters for retatrutide (a triple agonist of GLP-1, GIP and glucagon) research, compared with vial reconstitution and premixed pens.
- [Skin Peptides in a Pen: GHK-Cu and Glow Blend for Anti-Aging Research](https://penpeptides.is/skin-peptides-ghk-cu-glow-blend): copper peptide (GHK-Cu) and glow-blend skin research, and why oxidation makes traditional delivery formats unreliable.
- [HGH, Tesamorelin and MOTS-c: A Researcher's Guide to Performance and Longevity Peptide Pens](https://penpeptides.is/performance-longevity-peptides-hgh-tesamorelin-mots-c): three performance and longevity peptides, their strategies, and the delivery question that ties them together.

## Notes
- All content is for research and educational purposes only. The compounds discussed are not approved by the FDA, EMA, or any regulatory body for therapeutic use and are not intended for human consumption.